Quick Answer
FILANA THERAPEUTICS, INC. reported Net Income of -$90.97 million for fiscal year 2025.
FILANA THERAPEUTICS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$90.97M | -273.7% |
| 2024 | -$24.34M | +75.0% |
| 2023 | -$97.22M | -27.5% |
| 2022 | -$76.25M | -135.4% |
| 2021 | -$32.38M | -411.3% |
| 2020 | -$6.33M | -36.8% |
| 2019 | -$4.63M | +29.4% |
| 2018 | -$6.56M | +45.0% |
| 2017 | -$11.91M | +19.8% |
| 2016 | -$14.85M | -5.0% |
| 2015 | -$14.14M | -14.2% |
| 2014 | -$12.39M | -139.3% |
| 2013 | $31.54M | +1015.4% |
| 2012 | -$3.45M | -31.9% |
| 2011 | -$2.61M | +78.3% |
| 2010 | -$12.02M | -246.8% |
| 2009 | -$3.47M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$10.81M | +61.3% | +75.6% |
| June 30, 2025 | -$44.22M | -818.5% | -89.0% |
| March 31, 2025 | -$23.40M | -193.5% | +16.2% |
| September 30, 2024 | -$27.94M | -8.9% | -554.0% |
| June 30, 2024 | $6.16M | +123.3% | -75.4% |
| March 31, 2024 | $25.04M | +203.2% | +197.6% |
| September 30, 2023 | -$25.65M | -26.6% | +2.7% |
| June 30, 2023 | -$26.38M | -36.5% | -8.7% |
- FILANA THERAPEUTICS, INC. showed a decrease of -273.7% in Net Income compared to the prior fiscal year.
- Over the 2009–2025 period, FILANA THERAPEUTICS, INC.’s net income has declined by 2524.0% (from -$3.47 million to -$90.97 million).
- The most recent figure is from FILANA THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: